J&J's Gorsky makes $11 million after bonus cut, Weldon rakes in $30 million
This article was originally published in Scrip
Johnson & Johnson CEO Alex Gorsky made almost $11 million in his first year as head of the health care conglomerate, while his predecessor William Weldon pulled in nearly $30 million in 2012.
You may also be interested in...
Using Baxter’s Advate drug as a preventative therapy helped significantly reduce bleeding incidents in a yearlong study.
Mylan CEO Heather Bresch said she is looking to do a sizable deal that helps the US generic and specialty drug maker better compete in a consolidating field of rivals.
Biogen Idec CEO George Scangos is frank about his ambitions to dominate the market for hemophilia therapies, an opportunity he compares to the big biotech’s lead treating multiple sclerosis.